Humana (NYSE:HUM) Reaches New 1-Year High – What’s Next?

Humana Inc. (NYSE:HUM) shares hit a new 52-week high on Friday . The company traded as high as $381.98 and last traded at $384.2350, with a volume of 114015 shares changing hands. The stock had previously closed at $376.00.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on HUM shares. JPMorgan Chase & Co. increased their price objective on shares of Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a research note on Monday, June 8th. Evercore boosted their price objective on Humana from $250.00 to $370.00 in a research note on Thursday, June 11th. Leerink Partners boosted their target price on Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a report on Thursday, April 30th. Barclays upped their price objective on shares of Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. Finally, Zacks Research raised shares of Humana from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 13th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $293.09.

Humana Stock Up 0.6%

The company has a market cap of $45.42 billion, a price-to-earnings ratio of 40.48, a PEG ratio of 2.06 and a beta of 0.76. The firm’s fifty day simple moving average is $299.39 and its 200 day simple moving average is $244.75. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The company had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same period last year, the firm earned $11.58 earnings per share. Humana’s quarterly revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts predict that Humana Inc. will post 9.04 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s payout ratio is 37.86%.

Institutional Investors Weigh In On Humana

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HUM. Montag A & Associates Inc. raised its holdings in shares of Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after buying an additional 94 shares during the last quarter. CoreCap Advisors LLC boosted its stake in shares of Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after buying an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac acquired a new position in shares of Humana during the 4th quarter worth $27,000. Reflection Asset Management acquired a new position in Humana during the fourth quarter worth about $29,000. Finally, Rosenberg Matthew Hamilton increased its stake in Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.